It has been demonstrated that plasma levels of HSP90α were higher in most patients with cancer, and the expression of HSP90α may be prognostic markers in several solid tumors, including lung cancer, liver cancer, and breast cancer (18–20). Here, HSP90AA1 is linked to lung carcinoma.